Author:
Cafforio Paola,Dammacco Franco,Gernone Angela,Silvestris Franco
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,General Medicine
Reference51 articles.
1. Endo,A. ( 1994 ) The discovery and development of HMG-CoA reductase inhibitors. J. Lipid. Res. , 33 , 1569 –1582.
2. Goldstein,J.S. and Brown,M.S. ( 1990 ) Regulation of the mevalonate pathway. Nature , 343 , 425 –430.
3. Elson,C.E., Peffley,D.M., Hentosh,P. and Mo,H. ( 1999 ) Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proc. Soc. Exp. Biol. Med. , 221 , 294 –311.
4. Vogt,A., Qian,Y., McGuire,T.F., Hamilton,A.D. and Sebti,S.M. ( 1996 ) Protein geranyl-geranylation, not farnesylation, is required for the G 1 to S phase transition in mouse fibroblasts. Oncogene , 13 , 1991 –1999.
5. Yoshida,Y., Kawata,M., Katayama,M., Horiuchi,H., Kita,Y. and Takai,Y. ( 1991 ) A geranyl-geranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21S. Biochem. Biophys. Res. Commun. , 175 , 720 –728.
Cited by
214 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献